C.T. Fitzpatrick - Vulcan Value Partners,
Holding/activity history for Elevance Health Inc. (ELV)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 296,771 | 2.30 | Reduce 23.16% | 0.58 | $292.75 | $86,879,710 | SEC |
| 2025 Q4 | 386,214 | 2.49 | Reduce 7.87% | 0.19 | $350.64 | $135,424,000 | SEC |
| 2025 Q3 | 419,195 | 2.46 | Add 42.71% | 0.74 | $323.73 | $135,706,495 | SEC |
| 2025 Q2 | 293,731 | 2.18 | Reduce 22.47% | 0.69 | $421.57 | $123,827,013 | SEC |
| 2025 Q1 | 378,874 | 3.09 | Reduce 3.81% | 0.09 | $434.80 | $164,734,177 | SEC |
| 2024 Q4 | 393,892 | 2.43 | Add 41.04% | 0.71 | $368.71 | $145,233,542 | SEC |
| 2024 Q3 | 279,285 | 2.43 | Reduce 19.03% | 0.54 | $520.00 | $145,228,200 | SEC |
| 2024 Q2 | 344,938 | 2.85 | Reduce 11.50% | 0.34 | $541.39 | $186,745,000 | SEC |
| 2024 Q1 | 389,740 | 2.93 | Add 1.38% | 0.04 | $518.39 | $202,037,000 | SEC |
| 2023 Q4 | 384,417 | 2.66 | Reduce 14.48% | 0.43 | $471.96 | $181,430,000 | SEC |
| 2023 Q3 | 449,530 | 2.98 | Reduce 17.79% | 0.54 | $435.66 | $195,841,000 | SEC |
| 2023 Q2 | 546,818 | 3.05 | Add 34.68% | 0.79 | $444.30 | $242,950,000 | SEC |
| 2023 Q1 | 406,001 | 2.37 | Add 29.47% | 0.54 | $460.91 | $187,131,000 | SEC |
| 2022 Q4 | 313,598 | 2.16 | Reduce 19.81% | 0.41 | $512.20 | $160,626,000 | SEC |
| 2022 Q3 | 391,053 | 2.08 | Buy | 2.08 | $454.24 | $177,632,000 | SEC |
| 2021 Q4 | 0 | 0.00 | Sell 100.00% | 2.34 | SEC | ||
| 2021 Q3 | 1,168,878 | 2.34 | Reduce 0.99% | 0.02 | $372.80 | $435,757,000 | SEC |
| 2021 Q2 | 1,180,580 | 2.44 | Reduce 9.17% | 0.25 | $381.80 | $450,746,000 | SEC |
| 2021 Q1 | 1,299,779 | 2.76 | Reduce 28.48% | 1.07 | $358.95 | $466,556,000 | SEC |
| 2020 Q4 | 1,817,307 | 3.77 | Reduce 0.83% | 0.03 | $321.09 | $583,519,000 | SEC |
| 2020 Q3 | 1,832,485 | 3.83 | Add 0.33% | 0.01 | $268.59 | $492,187,000 | SEC |
| 2020 Q2 | 1,826,490 | 3.78 | Add 5.59% | 0.20 | $262.98 | $480,330,000 | SEC |
| 2020 Q1 | 1,729,827 | 4.07 | Reduce 7.26% | 0.32 | $227.04 | $392,740,000 | SEC |
| 2019 Q4 | 1,865,275 | 4.35 | Add 5.74% | 0.24 | $302.03 | $563,369,000 | SEC |
| 2019 Q3 | 1,764,073 | 3.58 | Add 50.26% | 1.20 | $240.10 | $423,554,000 | SEC |
| 2019 Q2 | 1,174,036 | 2.95 | Add 2,134,510.91% | 2.95 | $282.21 | $331,325,000 | SEC |
| 2019 Q1 | 55 | <0.01 | Reduce 3.51% | $290.91 | $16,000 | SEC | |
| 2018 Q4 | 57 | <0.01 | Reduce 75.64% | <0.01 | $263.16 | $15,000 | SEC |
| 2018 Q3 | 234 | <0.01 | Reduce 99.96% | 1.21 | $273.50 | $64,000 | SEC |
| 2018 Q2 | 636,193 | 1.21 | Reduce 51.20% | 1.19 | $238.03 | $151,433,000 | SEC |
| 2018 Q1 | 1,303,661 | 2.32 | Reduce 1.78% | 0.04 | $219.70 | $286,414,000 | SEC |
| 2017 Q4 | 1,327,283 | 2.48 | Add 52.14% | 0.85 | $225.01 | $298,652,000 | SEC |
| 2017 Q3 | 872,391 | 1.46 | Reduce 48.37% | 1.41 | $189.88 | $165,649,000 | SEC |
| 2017 Q2 | 1,689,616 | 2.91 | Reduce 2.38% | 0.06 | $188.13 | $317,867,000 | SEC |
| 2017 Q1 | 1,730,750 | 2.54 | Reduce 43.26% | 1.75 | $165.38 | $286,231,000 | SEC |
| 2016 Q4 | 3,050,319 | 4.04 | Reduce 3.53% | 0.13 | $143.77 | $438,544,000 | SEC |
| 2016 Q3 | 3,162,047 | 3.69 | Add 22.07% | 0.67 | $125.31 | $396,236,000 | SEC |
| 2016 Q2 | 2,590,276 | 3.51 | Add 0.14% | <0.01 | $131.34 | $340,207,000 | SEC |
| 2016 Q1 | 2,586,585 | 3.35 | Add 1.61% | 0.05 | $138.99 | $359,509,000 | SEC |
| 2015 Q4 | 2,545,577 | 3.25 | Add 67.90% | 1.31 | $139.44 | $354,956,000 | SEC |
| 2015 Q3 | 1,516,171 | 2.06 | Add 101.31% | 1.04 | $140.00 | $212,264,000 | SEC |
| 2015 Q2 | 753,137 | 1.17 | Add 46.18% | 0.37 | $164.14 | $123,620,000 | SEC |
| 2015 Q1 | 515,203 | 0.80 | Reduce 57.43% | 1.00 | $154.41 | $79,553,000 | SEC |
| 2014 Q4 | 1,210,332 | 1.74 | Buy | 1.74 | $125.67 | $152,103,000 | SEC |